Intellectual Property India Publishes Patent Application for 'Amide Derivatives For Inhibiting Nlrp3 And Uses Thereof' Filed by Ventus Therapeutics U. S. Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517099291 A) filed by Ventus Therapeutics U. S. Inc., Waltham, U.S.A., on Oct. 14, for 'amide derivatives for inhibiting nlrp3 and uses thereof.'

Inventor(s) include Dorich, Stephane; Beveridge, Ramsay E.; Ciblat, Stephane; Cote, Alexandre; Cyr, Patrick; and St-Onge, Miguel.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to compounds of Formula (I-A): and pharmaceutically acceptable salts and tautomers thereof, wherein Ring A, Ring B, R1, R2a, R2b, R3, m, n, and p are described herein, and methods of preparatio...